Showing 1 - 9 results of 9 for search 'Qitao Yu', query time: 0.03s
Refine Results
-
1
-
2
The benefit and risk of PD-1/PD-L1 inhibitors plus anti-angiogenic agents as second or later-line treatment for patients with advanced non-small-cell lung cancer: a systematic revi... by Shubin Chen, Wanying Mo, Wei Jiang, Shaozhang Zhou, Haijie Gan, Qitao Yu
Published 2023-08-01
Article -
3
Case Report: The effective treatment of patients in advanced no-small cell lung cancer patients with EGFR G719X/S768I/L861Q and acquired MET amplification: A case series and litera... by Yun Zhao, Cuiyun Su, Lina Shi, Wenqi Luo, Zhen Liu, Chuqiao Liang, Huilin Wang, Ruiling Ning, Qitao Yu, Wei Jiang
Published 2023-02-01
Article -
4
Targeting acetylcholine signaling modulates persistent drug tolerance in EGFR-mutant lung cancer and impedes tumor relapse by Meng Nie, Na Chen, Huanhuan Pang, Tao Jiang, Wei Jiang, Panwen Tian, LiAng Yao, Yangzi Chen, Ralph J. DeBerardinis, Weimin Li, Qitao Yu, Caicun Zhou, Zeping Hu
Published 2022-10-01
Article -
5
Envonalkib versus crizotinib for treatment-naive ALK-positive non-small cell lung cancer: a randomized, multicenter, open-label, phase III trial by Yunpeng Yang, Jie Min, Nong Yang, Qitao Yu, Ying Cheng, Yanqiu Zhao, Manxiang Li, Hong Chen, Shou’an Ren, Jianying Zhou, Wu Zhuang, Xintian Qin, Lejie Cao, Yan Yu, Jian Zhang, Jianxing He, Jifeng Feng, Hao Yu, Li Zhang, Wenfeng Fang
Published 2023-08-01
Article -
6
AK112, a novel PD-1/VEGF bispecific antibody, in combination with chemotherapy in patients with advanced non-small cell lung cancer (NSCLC): an open-label, multicenter, phase II tr... by Yuanyuan Zhao, Gang Chen, Jianhua Chen, Li Zhuang, Yingying Du, Qitao Yu, Wu Zhuang, Yanqiu Zhao, Ming Zhou, Weidong Zhang, Yu Zhang, Yixin Wan, Wenting Li, Weifeng Song, Zhongmin Maxwell Wang, Baiyong Li, Michelle Xia, Yunpeng Yang, Wenfeng Fang, Yan Huang, Li Zhang
Published 2023-08-01
Article -
7
SETD2 variation correlates with tumor mutational burden and MSI along with improved response to immunotherapy by Xiaobin Zheng, Jing Lin, Jiani Xiong, Yanfang Guan, Bin Lan, Yi Li, Xuan Gao, Zhaodong Fei, Lisha Chen, Lizhu Chen, Ling Chen, Gang Chen, Zengqing Guo, Xin Yi, Weiguo Cao, Xinghao Ai, Chengzhi Zhou, Xiaofeng Li, Jun Zhao, Xiangtao Yan, Qitao Yu, Lu Si, Yu Chen, Chuanben Chen
Published 2023-07-01
Article -
8
Central nervous system efficacy of furmonertinib (AST2818) in patients with EGFR T790M mutated non-small cell lung cancer: a pooled analysis from two phase 2 studies by Xingsheng Hu, Shucai Zhang, Zhiyong Ma, Jifeng Feng, Lin Wu, Dongqing Lv, Jianying Zhou, Xiaodong Zhang, Li Liu, Qitao Yu, Wangjun Liao, Yiping Zhang, Xiang Wang, Ying Cheng, Hongrui Niu, Ziping Wang, Dong Wang, Cheng Huang, Chunling Liu, Hui Zhao, Jian Feng, Jingzhang Li, Kejing Ying, Nong Yang, Shukui Qin, Jie Hu, Fei Liu, Yong Jiang, Nan Ge, Yuankai Shi
Published 2023-04-01
Article -
9
Chinese expert consensus on the diagnosis and treatment of bone metastasis in lung cancer (2022 edition) by Jianchun Duan, Wenfeng Fang, Hairong Xu, Jinliang Wang, Yuan Chen, Yi Ding, Xiaorong Dong, Yun Fan, Beili Gao, Jie Hu, Yan Huang, Cheng Huang, Dingzhi Huang, Wenhua Liang, Lizhu Lin, Hui Liu, Zhiyong Ma, Meiqi Shi, Yong Song, Chuanhao Tang, Jialei Wang, Lifeng Wang, Yongfeng Wang, Zhehai Wang, Nong Yang, Yu Yao, Yan Yu, Qitao Yu, Hongmei Zhang, Jun Zhao, Mingfang Zhao, Zhengfei Zhu, Xiaohui Niu, Li Zhang, Jie Wang
Published 2023-12-01
Article